ECOG-ACRIN EAY131/MATCH

Molecular Analysis for Therapy Choice (MATCH)

Objective

NCI-MATCH, also known as MATCH, is a precision medicine cancer treatment clinical trial. In this trial, patients are assigned to receive treatment based on the genetic changes found in their tumors through genomic sequencing and other tests.

Clinical Trial Categories

• Other

Contact

NH Oncology Hematology Clinical Research Dept. at (603) 224-2556